Minerva Neurosciences, Inc. - 8-K Filing

Minerva Neurosciences issues revised KOL event transcript to clarify regulatory statements regarding roluperidone. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $NERV

Read the full article at SEC EDGAR

Part of the story Nkarta, Inc. - 8-K Filing (3 articles)

More Regulatory news